Skip to main content

Acute-on-Chronic Liver Failure in Cirrhosis: Defining and Managing Organ Dysfunction

  • Conference paper
  • 1343 Accesses

Abstract

The term ‘acute-on-chronic liver failure’ was first used in the 1960s mainly in relation to flares of viral hepatitis. It was not until the turn of the millennium, however, that the term entered the everyday vocabulary of hepatologists when it was used to describe the pathophysiological deterioration in patients with cirrhosis mainly in the context of trials utilizing liver support devices [1]. Since then, a consensus definition of acute-on-chronic liver failure has been fiercely debated. The terms ‘compensated’ and ‘decompensated’ liver disease are rarely used in the critical care arena with patients being defined with regard to the degree of organ dysfunction rather than by quantifying liver synthetic function per se. Moreover, it has been shown that the prognosis in patients with cirrhosis is strongly correlated with the number of failing organs [24] and that certain cohorts of patients with severe hepatic encephalopathy, acute variceal bleeding, and organ failure benefit from admission to a critical care environment [5].

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sen S, Davies NA, Mookerjee RP, et al (2004) Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl 10: 1109–1119

    Article  PubMed  Google Scholar 

  2. Gildea TR, Cook WC, Nelson DR, et al (2004) Predictors of long-term mortality in patients with cirrhosis of the liver admitted to a medical ICU. Chest 126: 1598–1603

    Article  PubMed  Google Scholar 

  3. Cholongitas E, Senzolo M, Patch D, et al (2006) Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther 23: 883–893

    Article  CAS  PubMed  Google Scholar 

  4. Zimmerman JE, Wagner DP, Seneff MG, Becker RB, Sun X, Knaus WA (1996) Intensive care unit admissions with cirrhosis: risk-stratifying patient groups and predicting individual survival. Hepatology 23: 1393–1401

    Article  CAS  PubMed  Google Scholar 

  5. Shawcross D, Austin M, Abeles R, et al (2008) Defining the impact of organ dysfunction in cirrhosis: survival at a cost? Gut 57 (Suppl 1):A12–A13 (abst)

    Google Scholar 

  6. Levy M, Fink M, Marshall J, et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29: 530–538

    PubMed  Google Scholar 

  7. Rivers E, Nguyen B, Havastad S, et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368–1377

    Article  CAS  PubMed  Google Scholar 

  8. Knaus W, Draper E, Wagner D, Zimmerman J (1985) Prognosis in acute organ-system failure. Ann Surg 202: 685–693

    Article  CAS  PubMed  Google Scholar 

  9. Vincent JL, Moreno R, Takala J, et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22: 707–710

    Article  CAS  PubMed  Google Scholar 

  10. Austin M, Shawcross D (2008) Outcome of patients with cirrhosis admitted to intensive care. Curr Opin Crit Care 14: 202–207

    Article  PubMed  Google Scholar 

  11. Pugh R, Murray-Lyon I, Dawson J, Pietroni M, Williams R (1973) Transection of the oesophagus for bleeding oesphageal varices. Br J Surg 60: 646–649

    Article  CAS  PubMed  Google Scholar 

  12. Kamath K, Weisner R, Malinchoc M, et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33: 464–470

    Article  CAS  PubMed  Google Scholar 

  13. Jenq C, Tsai M, Tain Y, et al (2007) RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients. Intensive Care Med 33: 1921–1930

    Article  PubMed  Google Scholar 

  14. Wasmuth H, Kunz D, Yagmur E, et al (2005) Patients with acute on chronic liver failure display’ sepsis-like’ immune paralysis. J Hepatol 42: 195–201

    Article  CAS  PubMed  Google Scholar 

  15. Wong F, Bernardi M, Balk R, et al (2005) Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 54: 718–725

    Article  CAS  PubMed  Google Scholar 

  16. Antoniades CG, Berry PA, Davies ET, et al (2006) Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 44: 34–43

    Article  CAS  PubMed  Google Scholar 

  17. Jalan R, Newby DE, Damink SW, Redhead DN, Hayes PC, Lee A (2001) Acute changes in cerebral blood flow and metabolism during portasystemic shunting. Liver Transpl 7: 274–278

    Article  CAS  PubMed  Google Scholar 

  18. Van der Linden P, Le Moine O, Ghysels M, Ortinez M, Deviere J (1996) Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function. Hepatology 23: 982–987

    Article  PubMed  Google Scholar 

  19. Harry R, Auzinger G, Wendon J (2002) The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology 36: 395–402

    Article  CAS  PubMed  Google Scholar 

  20. Marik P, Gayowski T, Starzl T (2005) The hepatoadrenal syndrome: a common yet unrecognised clinical condition. Crit Care Med 33: 1254–1259

    Article  PubMed  Google Scholar 

  21. Fernandez J, Escorsell A, Zabalza M, et al (2006) Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival. Hepatology 44: 1288–1295

    Article  CAS  PubMed  Google Scholar 

  22. Ferenci P, Lockwood A, Mullen K, et al (2002) Hepatic Encephalopathy — Definition, nomenclature, diagnosis and quantification: Final report of the Working Party at the 11th World Congress of Gastroenterology, Vienna, 1998. Hepatology 35: 716–721

    Article  PubMed  Google Scholar 

  23. Cordoba J, Alonso J, Rovira A, et al (2001) The development of low-grade cerebral oedema in cirrhosis is supported by the evolution of 1H-magnetic resonance abnormalities after liver transplantation. J Hepatol 35: 598–604

    Article  CAS  PubMed  Google Scholar 

  24. Als-Nielsen B, Gluud L, Gluud C (2004)Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ 328: 1046–1050

    Article  CAS  PubMed  Google Scholar 

  25. Cordoba J, Lopez-Hellin J, Planas M, et al (2004) Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol 41: 38–43

    Article  CAS  PubMed  Google Scholar 

  26. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R (2000) The systemic inflammatory response syndrome in acute liver failure. Hepatology 32: 734–739

    Article  CAS  PubMed  Google Scholar 

  27. Shawcross D, Davies N, Williams R, Jalan R (2004) Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40: 247–254

    Article  CAS  PubMed  Google Scholar 

  28. Liu Q, Duan ZP, Ha dK, Bengmark S, Kurtovic J, Riordan SM (2004) Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39: 1441–1449

    Article  PubMed  Google Scholar 

  29. Hassanein T, Tofteng F, Brown R, et al (2007) Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 46: 1853–1862

    Article  CAS  PubMed  Google Scholar 

  30. Bernal W, Auzinger G, Sizer E, Wendon J (2008) Intensive care management for acute liver failure. Semin Liver Dis 28: 188–200

    Article  PubMed  Google Scholar 

  31. Chau T, Chan Y, Patch D, Tokanuga S, Greenslade L, Burroughs A (1998) Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding. Gut 43: 267–271

    Article  CAS  PubMed  Google Scholar 

  32. Papatheodoridis G, Patch D, Webster G, Brooker J, Barnes E, Burroughs A (1999) Infection and hemostasis in decompensated cirrhosis: a prospective study using thrombelastography. Hepatology 29: 1085–1090

    Article  CAS  PubMed  Google Scholar 

  33. Fernandez-Seara J, Prieto J, Quiroga J, et al (1989) Systemic and regional haemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology 97: 1304–1312

    CAS  PubMed  Google Scholar 

  34. Moller S, Henriksen J (2008) Cardiovascular complications of cirrhosis. Gut 57: 268–278

    Article  CAS  PubMed  Google Scholar 

  35. Russell J, Walley K, Singer J, et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358: 877–887

    Article  CAS  PubMed  Google Scholar 

  36. Annane D, Sebille V, Charpentier C, et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862–871

    Article  CAS  PubMed  Google Scholar 

  37. Malbrain M, Chiumello D, Pelosi P, et al (2004) Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med 30: 822–829

    Article  PubMed  Google Scholar 

  38. Rajkovic IA, Williams R (1986) Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 6: 252–262

    Article  CAS  PubMed  Google Scholar 

  39. Trevisani F, Castelli E, Foschi FG, et al (2002) Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome. Gut 50: 707–712

    Article  CAS  PubMed  Google Scholar 

  40. Mookerjee R, Stadlbauer V, Lidder S, et al (2007) Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts outcome. Hepatology 46: 831–840

    Article  CAS  PubMed  Google Scholar 

  41. Shawcross D, Wright G, Stadlbauer V, et al (2008) Ammonia impairs neutrophil phagocytic function in liver disease. Hepatology 48: 1202–1212

    Article  CAS  PubMed  Google Scholar 

  42. Borroni G, Maggi A, Sangiovanni A, Cazzaniga M, Salerno F (2000) Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis 32: 605–610

    Article  CAS  PubMed  Google Scholar 

  43. Olde Damink S, Jalan R, Deutz N, et al (2003) The kidney plays a major role in the hyperammonemia seen after a simulated or actual upper gastrointestinal bleeding in patients with cirrhosis. Hepatology 37: 1277–1285

    Article  PubMed  Google Scholar 

  44. Walker S, Stiehl A, Raedsch R, Kommerell B (1986) Terlipressin in bleeding oesphageal varices: a placebo-controlled, double blind study. Hepatology 6: 112–115

    Article  CAS  PubMed  Google Scholar 

  45. Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, et al (2004) Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40: 793–801

    PubMed  Google Scholar 

  46. Laine L, Planas R, Nevens F, Banares R, Patch D, Bosch J (2006) Treatment of the acute bleeding episode. In: De Franchis R (ed) Portal Hypertension IV: Proceedings of the Fourth Baveno International Consensus Workshop. Blackwell Publishing, Boston, pp217–242

    Google Scholar 

  47. Salerno F, Gerbes A, Gines P, Wong F, Arroyo V (2007) Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56: 1310–1318

    CAS  PubMed  Google Scholar 

  48. Ortega R, Gines P, Uriz J, et al (2002) Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, non randomised study. Hepatology 36: 941–948

    CAS  PubMed  Google Scholar 

  49. VA/NIH Acute Renal Failure Trial Network (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 7–20

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Shawcross, D., Wendon, J. (2009). Acute-on-Chronic Liver Failure in Cirrhosis: Defining and Managing Organ Dysfunction. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-92278-2_61

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-92278-2_61

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-92277-5

  • Online ISBN: 978-0-387-92278-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics